Hormone receptor positive (HR +), human epidermal growth factor receptor 2 negative (HER2−) is the most prevalent subtype of invasive breast cancer and accounts for approximately 70% of all cases [1]. This evidence concerns the gene ERBB2 and invasive breast carcinoma.